Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

1093.HK Gross Margin

The Gross Margin of CSPC Pharmaceutical Group Ltd (1093.HK) is 69.97%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

1093.HK Gross Margin - Historical Value
Date Value
2024-12-31 69.97%
2023-12-31 70.51%
2022-12-31 71.94%
2021-12-31 75.84%
2020-12-31 74.91%
2019-12-31 71.98%
2018-12-31 66.25%
2017-12-31 60.44%
2016-12-31 51.00%
2015-12-31 45.82%
1093.HK Gross Margin - Peers Comparison
Ticker Name Value
300558.SZ Betta Pharmaceuticals Co Ltd 81.38%
600079.SS Humanwell Healthcare Group Co Ltd 44.47%
603707.SS Nanjing King-friend Biochemical Pharmaceutical Co Ltd 46.17%
000513.SZ Livzon Pharmaceutical Group Inc 64.80%
002422.SZ Sichuan Kelun Pharmaceutical Co Ltd 51.35%
600436.SS Zhangzhou Pientzehuang Pharmaceutical Co Ltd 42.63%
600535.SS Tasly Pharmaceutical Group Co Ltd 66.94%
002773.SZ Chengdu Kanghong Pharmaceutical Group Co Ltd 89.46%
2096.HK Simcere Pharmaceutical Group Ltd 80.25%
600420.SS Shanghai Shyndec Pharmaceutical Co Ltd 37.94%
600521.SS Zhejiang Huahai Pharmaceutical Co Ltd 60.64%
603858.SS Shandong Buchang Pharmaceuticals Co Ltd 59.04%
867.HK China Medical System Holdings Ltd 72.60%
000739.SZ Apeloa Pharmaceutical Co Ltd 23.26%
002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd 46.47%
002821.SZ Asymchem Laboratories Tianjin Co Ltd 41.55%
600267.SS Zhejiang Hisun Pharmaceutical Co Ltd 43.80%
600380.SS Joincare Pharmaceutical Group Industry Co Ltd 62.13%
600812.SS North China Pharmaceutical Co Ltd 31.84%
000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co Ltd 51.36%
600085.SS Beijing Tongrentang Co Ltd 43.56%
600196.SS Shanghai Fosun Pharmaceutical Group Co Ltd 47.83%
000538.SZ Yunnan Baiyao Group Co Ltd 27.77%
002001.SZ Zhejiang Nhu Co Ltd 41.55%
002653.SZ Haisco Pharmaceutical Group Co Ltd 71.47%
000661.SZ Changchun High-Tech Industry Group Co Ltd 84.64%
002019.SZ Yifan Pharmaceutical Co Ltd 46.79%
002294.SZ Shenzhen Salubris Pharmaceuticals Co Ltd 71.63%